Invicta Diagnostic IPO
GMP, Subscription, Price, Dates & Financial Details
Healthcare Services
Incorporated in January 2021, Invicta Diagnostics Limited is a Mumbai-based diagnostic services provider offering comprehensive radiology and pathology solutions under its brand “PC Diagnostics.” The company operates through a hub-and-spoke model across the Mumbai Metropolitan Region, delivering…
Open Date
Mon, 01 Dec 2025
Close Date
Wed, 03 Dec 2025
Price Band
₹ 80 – 85
Lot Size
1600
Issue Size
₹ 28.12 Cr
Minimum Investment
₹ 272,000 (3200 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Invicta Diagnostic IPO has successfully completed its IPO process and is now listed on NSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹28.12 Crore.
The Invicta Diagnostic IPO remained open for subscription from December 01, 2025, to December 03, 2025. The basis of allotment was finalized on December 04, 2025, and the company's shares were listed on NSE SME Platform on December 08, 2025.
The company had fixed the price band at ₹80 to ₹85 per share, with a lot size of 1600 shares. Retail investors were required to make a minimum investment of ₹272,000 (based on the upper price band) to apply for one lot.
Bigshare Services Pvt Ltd served as the registrar to the issue. Socradamus Capital Private Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Invicta Diagnostic Limited is now a publicly listed company on NSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Invicta Diagnostic IPO Timeline (Tentative)
- IPO Open Date
- Mon, 01 Dec 25
- IPO Close Date
- Wed, 03 Dec 25
- Basis of Allotment
- Thu, 04 Dec 25
- Initiation of Refunds
- Fri, 05 Dec 25
- Credit of Shares to Demat
- Fri, 05 Dec 25
- Listing Date
- Mon, 08 Dec 25 — NSE & BSE
Open Date
01 December 2025
Close Date
03 December 2025
Basis Of Allotment
04 December 2025
Listing Date
08 December 2025
IPO Subscription
Check Live Subscription →The Invicta Diagnostic IPO has received bids for 1,01,77,600 shares against 23,44,000 shares offered, resulting in an overall subscription of 4.34x. the NII category is subscribed 7.27x, Retail Investors 3.44x, and QIBs 3.51x. Within the NII category, BNII is subscribed 7.76x, while SNII is subscribed 6.27x.
QIB
3.51x
NII
7.27x
BNII
7.76x
SNII
6.27x
RII
3.44x
Total
4.34x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 12,67,200 shares, representing 54.06% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 5,34,400 shares (22.8%), while Non-Institutional Investors (NIIs) receive 5,42,400 shares (23.14%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 534,400 | 22.8% |
| Non-Institutional | 542,400 | 23.14% |
| BNII | 361,600 | 15.43% |
| SNII | 180,800 | 7.71% |
| Retail Investors | 1,267,200 | 54.06% |
| Total | 2,344,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Assets | 21.22 | 15.89 |
| Revenue | 30.18 | 15.9 |
| Profit After Tax | 4.93 | 3.81 |
| Net Worth | 13.6 | 8.67 |
| Reserve & Surplus | 5.18 | 8.54 |
| Total Borrowings | 3.54 | 3.81 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Invicta Diagnostic Limited KPI Information
| Particular | Mar 2025 | Mar 2024 |
|---|---|---|
| ROE % | 44.28 | 55.53 |
| ROCE % | 42 | 56.04 |
| Debt / Equity | 0.26 | 0.44 |
| RoNW % | 36.25 | 43.9 |
| Pat Margin % | 16.38 | 24.04 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Invicta Diagnostic Ltd | 10 | 0.00 | 5.86 | 5.86 | 36.25 | 16.15 |
| Vijaya Diagnostic Centre Ltd | 1 | 72.22 | 13.95 | 13.95 | 17.99 | 77.86 |
| Krsnaa Diagnostics Ltd | 5 | 34.39 | 24.04 | 24.04 | 8.79 | 272.54 |
About Invicta Diagnostic Limited
Incorporated in January 2021, Invicta Diagnostics Limited is a Mumbai-based diagnostic services provider offering comprehensive radiology and pathology solutions under its brand “PC Diagnostics.” The company operates through a hub-and-spoke model across the Mumbai Metropolitan Region, delivering accessible, high-quality diagnostic services.
Operational Footprint
Invicta Diagnostics manages 7 diagnostic centres and one central laboratory across Mumbai, comprising:
- Flagship Hub – Thane West:
Full-spectrum pathology services along with advanced radiology, including CT and MRI. - Three Additional Hubs – Bhayandar, Byculla, Marol:
Offering specialized diagnostic tests and imaging services. - Four Spoke Centres – Lower Parel, Sewri, Mazgaon, Kalwa:
Focused on basic imaging (X-ray, ultrasound) and sample collection.
Test Portfolio
Invicta Diagnostics provides an extensive range of tests, including:
- Pathology:
~60 routine tests and ~487 specialized tests. - Radiology:
~96 basic and ~130 advanced radiology tests.
Key Services
- Routine Pathology Tests:
CBC, lipid profile, liver function (LFT), kidney function (KFT), thyroid panels. - Specialized Pathology Tests:
Molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels. - Radiology Services:
X-ray, ultrasound, CT, MRI, and teleradiology services. - Sample Collection Network:
Home collection via trained phlebotomists and sample collection at spoke centres, ensuring wide patient reach.
Team Strength
As of May 31, 2025, the company’s workforce includes:
- 5 laboratory doctors
- 20 radiologists
- 127 trained technical staff
- 105 permanent employees in total
Invicta Diagnostic IPO Promoters
- Dr. Ketan Jayantilal Jain
- Dr. Sanket Vinod Jain
- Rohit Prakash Srivastava
- Badal Kailash Naredi
- Jayesh Prakash Jain
Promoters Holding
Holding Pre Issue
90.52%
Holding Post Issue
0.00%
Invicta Diagnostic IPO Objective
The Company Invicta Diagnostic IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra
- General Corporate purposes
Invicta Diagnostic Limited Address / Contact Details
Invicta Diagnostic Ltd.
1 GF, Plot 217, Ambavat Bhavan
N.M Joshi Marg,Delisle Road
Mumbai, Maharashtra, 400013
Phone: 022 - 4971 0036
Email: investors@pcdiagnostics.in
Website: https://www.pcdiagnostics.in/
IPO Snapshot
Invicta Diagnostic IPO Lot Size
The Invicta Diagnostic IPO has a lot size of 1,600 shares. Retail investors require a minimum investment of ₹2,72,000 by applying for 2 lot (3,200 shares). The maximum application allowed for the retail category is 2 lots (3,200 shares), requiring an investment of ₹2,72,000.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 3,200 | 272,000.00 |
| Retail (Max) | 2 | 3,200 | 272,000.00 |
| S-HNI (Min) | 3 | 4,800 | 408,000.00 |
| S-HNI (Max) | 7 | 11,200 | 952,000.00 |
| B-HNI (Min) | 8 | 12,800 | 1,088,000.00 |
Issue Reservation
- QIB — 22.8%
- NII — 23.14%
- RII — 54.06%
Book Running Lead Managers
- Socradamus Capital Private Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Invicta Diagnostic IPO?
Invicta Diagnostic IPO is a Book-building IPO with a total issue size of ₹28.12 crore. The Invicta Diagnostic IPO price band is ₹80 to 85 per share. The Invicta Diagnostic IPO subscription opens on Mon, Dec 1, 2025, and closes on Wed, Dec 3, 2025. The Invicta Diagnostic IPO will be listed on the NSE. Bigshare Services Pvt Ltd is the registrar for the Invicta Diagnostic IPO.
When will the Invicta Diagnostic IPO open for subscription?
The Invicta Diagnostic IPO opens on Mon, Dec 1, 2025 and closes on Wed, Dec 3, 2025
What is Invicta Diagnostic IPO Price Band?
Invicta Diagnostic IPO Price Band is ₹80 to 85 per share.
What is Invicta Diagnostic IPO Lot Size?
Invicta Diagnostic IPO lot size is 1600 shares, Retail investors need a minimum investment of ₹272000 based on the upper price band
What is the minimum investment for Invicta Diagnostic IPO?
The minimum investment for Invicta Diagnostic IPO is ₹272000, based on one lot of 1600 shares at the upper price band of ₹85 per share.
How to apply for Invicta Diagnostic IPO?
Investors can apply for the Invicta Diagnostic IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Wed, Dec 3, 2025. The application amount remains blocked until the Invicta Diagnostic IPO allotment is finalized.
What is Invicta Diagnostic IPO Issue Size?
Invicta Diagnostic IPO issue size is ₹28.12 crores.
What is the Invicta Diagnostic IPO Allotment Date?
Invicta Diagnostic IPO allotment date is Thu, Dec 4, 2025.
Who is the Invicta Diagnostic IPO Registrar?
The registrar for Invicta Diagnostic IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Invicta Diagnostic IPO allotment status, refund processing, and other IPO-related information.
What is the Invicta Diagnostic IPO GMP?
The Invicta Diagnostic IPO GMP (Grey Market Premium) is ₹0 as of Mon, Dec 8, 2025. Based on the upper price band of ₹85 per share, the estimated Invicta Diagnostic IPO listing price is ₹85, indicating a potential listing gain of approximately 0.00% over the issue price.
Who is the Invicta Diagnostic IPO Lead Manager?
The book-running lead managers (BRLMs) for the Invicta Diagnostic IPO are Socradamus Capital Private Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Invicta Diagnostic IPO Red Herring Prospectus (RHP).